New York's top financial watchdog is at odds with American International Group Inc. over the next steps in federal court to resolve a potentially costly licensing dispute, as an unusual confrontation between the big insurer and a key regulator unfolds.
Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.
A patent dispute between Medtronic and Edwards Lifesciences over a potentially lifesaving artificial heart valve is prompting a scramble among doctors and hospitals to treat desperately ill elderly patients before a court injunction curtails sale of one of the devices.